BIOMAT Database Logo BIOMAT Database Logo

Prevalence of hemochromatosis gene (HFE) mutations in Greek patients with myelodysplastic syndromes. 2003

Matthaios Speletas, and Anna Kioumi, and Eudokia Mandala, and Eirini Katodritou, and Georgia Papaioannou, and Konstantinos Ritis, and Ioannis Korantzis
Haematology Department, Papageorgiou General Hospital, Thessaloniki, Greece. speletas@otenet.gr

UI MeSH Term Description Entries
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D009190 Myelodysplastic Syndromes Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA. Dysmyelopoietic Syndromes,Hematopoetic Myelodysplasia,Dysmyelopoietic Syndrome,Hematopoetic Myelodysplasias,Myelodysplasia, Hematopoetic,Myelodysplasias, Hematopoetic,Myelodysplastic Syndrome,Syndrome, Dysmyelopoietic,Syndrome, Myelodysplastic,Syndromes, Dysmyelopoietic,Syndromes, Myelodysplastic
D006115 Greece A country in southern Europe, bordering the Aegean Sea, Ionian Sea, and the Mediterranean Sea, between Albania and Turkey. The capital is Athens. Crete,Macedonia (Greece)
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071020 Hemochromatosis Protein A membrane protein and MHC class I antigen. It contains an IMMUNOGLOBULIN C1-SET DOMAIN and interacts with BETA 2-MICROGLOBULIN. It may also regulate the interaction of TRANSFERRIN with the TRANSFERRIN RECEPTOR. Mutations in the HFE gene are associated with cases of FAMILIAL HEMOCHROMATOSIS. HFE Protein,HLA-H Antigen,Antigen, HLA-H,HLA H Antigen
D015395 Histocompatibility Antigens Class I Membrane glycoproteins consisting of an alpha subunit and a BETA 2-MICROGLOBULIN beta subunit. In humans, highly polymorphic genes on CHROMOSOME 6 encode the alpha subunits of class I antigens and play an important role in determining the serological specificity of the surface antigen. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognized during GRAFT REJECTION and restrict cell-mediated lysis of virus-infected cells. Class I Antigen,Class I Antigens,Class I Histocompatibility Antigen,Class I MHC Protein,Class I Major Histocompatibility Antigen,MHC Class I Molecule,MHC-I Peptide,Class I Histocompatibility Antigens,Class I Human Antigens,Class I MHC Proteins,Class I Major Histocompatibility Antigens,Class I Major Histocompatibility Molecules,Human Class I Antigens,MHC Class I Molecules,MHC-I Molecules,MHC-I Peptides,Antigen, Class I,Antigens, Class I,I Antigen, Class,MHC I Molecules,MHC I Peptide,MHC I Peptides,Molecules, MHC-I,Peptide, MHC-I,Peptides, MHC-I
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

Matthaios Speletas, and Anna Kioumi, and Eudokia Mandala, and Eirini Katodritou, and Georgia Papaioannou, and Konstantinos Ritis, and Ioannis Korantzis
Prevalence of HFE (hemochromatosis) gene mutations in patients with cluster headache.
October 2005, Headache,
Matthaios Speletas, and Anna Kioumi, and Eudokia Mandala, and Eirini Katodritou, and Georgia Papaioannou, and Konstantinos Ritis, and Ioannis Korantzis
Prevalence of hemochromatosis gene (HFE) mutations in Greece.
January 2003, Acta haematologica,
Matthaios Speletas, and Anna Kioumi, and Eudokia Mandala, and Eirini Katodritou, and Georgia Papaioannou, and Konstantinos Ritis, and Ioannis Korantzis
Prevalence of hemochromatosis related HFE gene mutations in patients with acute myeloid leukemia.
June 1999, Leukemia research,
Matthaios Speletas, and Anna Kioumi, and Eudokia Mandala, and Eirini Katodritou, and Georgia Papaioannou, and Konstantinos Ritis, and Ioannis Korantzis
[Study on HFE gene mutations in patients with myelodysplastic syndromes and aplastic anemia].
April 2009, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
Matthaios Speletas, and Anna Kioumi, and Eudokia Mandala, and Eirini Katodritou, and Georgia Papaioannou, and Konstantinos Ritis, and Ioannis Korantzis
Prevalence of HFE (hemochromatosis gene) mutations in unselected male patients with type 2 diabetes.
February 2000, The Journal of laboratory and clinical medicine,
Matthaios Speletas, and Anna Kioumi, and Eudokia Mandala, and Eirini Katodritou, and Georgia Papaioannou, and Konstantinos Ritis, and Ioannis Korantzis
Analysis of HFE and non-HFE gene mutations in Brazilian patients with hemochromatosis.
January 2009, Clinics (Sao Paulo, Brazil),
Matthaios Speletas, and Anna Kioumi, and Eudokia Mandala, and Eirini Katodritou, and Georgia Papaioannou, and Konstantinos Ritis, and Ioannis Korantzis
Hemochromatosis-associated gene mutations in patients with myelodysplastic syndromes with refractory anemia with ringed sideroblasts.
December 2007, American journal of hematology,
Matthaios Speletas, and Anna Kioumi, and Eudokia Mandala, and Eirini Katodritou, and Georgia Papaioannou, and Konstantinos Ritis, and Ioannis Korantzis
Distribution of HFE gene mutations in Slovenian patients with hereditary hemochromatosis.
August 2008, Annals of hematology,
Matthaios Speletas, and Anna Kioumi, and Eudokia Mandala, and Eirini Katodritou, and Georgia Papaioannou, and Konstantinos Ritis, and Ioannis Korantzis
Prevalence of hemochromatosis-related symptoms among individuals with mutations in the HFE gene.
June 2002, Mayo Clinic proceedings,
Matthaios Speletas, and Anna Kioumi, and Eudokia Mandala, and Eirini Katodritou, and Georgia Papaioannou, and Konstantinos Ritis, and Ioannis Korantzis
Hemochromatosis (HFE) gene mutations in Brazilian chronic hemodialysis patients.
September 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
Copied contents to your clipboard!